1. Shi T, McAllister DA, O’Brien KL, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017;390(10098):946-958. doi:10. 1016/s0140-6736(17)30938-8
2. Wang X, Li Y, Shi T, et al. Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data. Lancet. 2024;403(10433):1241-1253. doi:10.1016/s0140-6736(24)00138-7
3. Duray AM, Lee B, Abood RN, et al. Predicting infectious etiology and severity in hospitalized pediatric pneumonia using blood cytokine biomarkers. Front Pediatr. 2025:13. doi:10.3389/fped.2025.1693879
4. Soto-Martínez ME, Acuña Cordero R, Parra-Buitrago A, et al. Respiratory Syncytial Virus in Pediatrics: Update on Epidemiology, Management, Long-term Consequences and Prevention. Consensus From Asociación Latinoamericana de Tórax (ALAT) 2025. Arch Bronconeumol. 2026. doi:10.1016/j.arbres.2026.01.009
5. Chen H, Zhang L, Nie X, et al. Epidemiology and mortality risk of severe viral pneumonia during the pre-pandemic, COVID-19 pandemic and post-pandemic era: a retrospective study of hospitalized children in ShenZhen, China between 2017 and 2023. J Epidemiol Global Health. 2025;15:1. doi:10.1007/s44197-025-00398-7
6. Caserta MT, O’Leary ST, Munoz FM, et al. Palivizumab prophylaxis in infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics. 2023;152:1. doi:10.1542/peds.2023-061803
7. Li Y, Wang X, Blau DM, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022;399(10340):2047-2064. doi:10.1016/s0140-6736 (22)00478-0
8. Agha R, Avner JR. Delayed seasonal RSV surge observed during the COVID-19 pandemic. Pediatrics. 2021;148:3. doi:10.1542/peds.2021-052089
9. Cohen R, Levy C, Rybak A, Angoulvant F, Ouldali N, Grimprel E. Immune debt: recrudescence of disease and confirmation of a contested concept. Infectious Diseases Now. 2023;53:2. doi:10.1016/j.idnow.2022. 12.003
10. Foley DA, Yeoh DK, Minney-Smith CA, et al. The interseasonal resurgence of respiratory syncytial virus in australian children following the reduction of Coronavirus disease 2019-related public health measures. Clin Infect Dis. 2021;73(9):e2829-e2830. doi:10.1093/cid/ciaa1906
11. Friedrich F, Ongaratto R, Scotta MC, et al. Early impact of social distancing in response to coronavirus disease 2019 on hospitalizations for acute bronchiolitis in infants in Brazil. Clin Infect Dis. 2021;72(12):2071-2075. doi:10.1093/cid/ciaa1458
12. Li Y, Reeves RM, Wang X, et al. Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis. Lancet Global Health. 2019; 7(8):e1031-e1045. doi:10.1016/s2214-109x(19)30264-5
13. Olsen SJ, Azziz-Baumgartner E, Budd AP, et al. Decreased influenza activity during the COVID-19 pandemic-United States, Australia, Chile, and South Africa, 2020. MMWR Morbidity and Mortality Weekly Report. 2020;69(37):1305-1309. doi:10.15585/mmwr.mm6937a6
14. Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360(6): 588-598. doi:10.1056/NEJMoa0804877
15. Munywoki PK, Koech DC, Agoti CN, et al. Frequent asymptomatic respiratory syncytial virus infections during an epidemic in a rural Kenyan household cohort. J Infect Dis. 2015;212(11):1711-1718. doi:10. 1093/infdis/jiv263
16. Raschetti R, Vivanti AJ, Vauloup-Fellous C, Loi B, Benachi A, De Luca D. Synthesis and systematic review of reported neonatal SARS-CoV-2 infections. Nature Communications. 2020;11:1. doi:10.1038/s41467-020-18982-9
17. Gale C, Quigley MA, Placzek A, et al. Characteristics and outcomes of neonatal SARS-CoV-2 infection in the UK: a prospective national cohort study using active surveillance. Lancet Child Adolesc Health. 2021;5(2):113-121. doi:10.1016/s2352-4642(20)30342-4
18. Brueggemann AB, Jansen van Rensburg MJ, Shaw D, et al. Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the invasive respiratory infection surveillance initiative: a prospective analysis of surveillance data. Lancet Digit Health. 2021;3(6):e360-e370. doi:10.1016/s2589-7500(21)00077-7
19. Florin TA, Plint AC, Zorc JJ. Viral bronchiolitis. Lancet. 2017;389(10065): 211-224. doi:10.1016/s0140-6736(16)30951-5
20. Zar HJ, Nduru P, Stadler JAM, et al. Early-life respiratory syncytial virus lower respiratory tract infection in a South African birth cohort: epidemiology and effect on lung health. Lancet Glob Health. 2020;8(10): e1316-e1325. doi:10.1016/s2214-109x(20)30251-5